These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 25633836

  • 1. Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
    Xie L, Pi X, Wang Z, He J, Willis MS, Patterson C.
    J Mol Cell Cardiol; 2015 Mar; 80():156-65. PubMed ID: 25633836
    [Abstract] [Full Text] [Related]

  • 2. Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.
    Adluri RS, Thirunavukkarasu M, Dunna NR, Zhan L, Oriowo B, Takeda K, Sanchez JA, Otani H, Maulik G, Fong GH, Maulik N.
    Antioxid Redox Signal; 2011 Oct 01; 15(7):1789-97. PubMed ID: 21083501
    [Abstract] [Full Text] [Related]

  • 3. Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction.
    Oriowo B, Thirunavukkarasu M, Selvaraju V, Adluri RS, Zhan L, Takeda K, Fong GH, Sanchez JA, Maulik N.
    Curr Pharm Des; 2014 Oct 01; 20(9):1305-10. PubMed ID: 23978105
    [Abstract] [Full Text] [Related]

  • 4. Prolyl hydroxylase 3 interacts with Bcl-2 to regulate doxorubicin-induced apoptosis in H9c2 cells.
    Liu Y, Huo Z, Yan B, Lin X, Zhou ZN, Liang X, Zhu W, Liang D, Li L, Liu Y, Zhao H, Sun Y, Chen YH.
    Biochem Biophys Res Commun; 2010 Oct 15; 401(2):231-7. PubMed ID: 20849813
    [Abstract] [Full Text] [Related]

  • 5. Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia.
    Rishi MT, Selvaraju V, Thirunavukkarasu M, Shaikh IA, Takeda K, Fong GH, Palesty JA, Sanchez JA, Maulik N.
    Microvasc Res; 2015 Jan 15; 97():181-8. PubMed ID: 25446011
    [Abstract] [Full Text] [Related]

  • 6. Dexmedetomidine post-treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF-1α signalling.
    Peng K, Chen WR, Xia F, Liu H, Meng XW, Zhang J, Liu HY, Xia ZY, Ji FH.
    J Cell Mol Med; 2020 Jan 15; 24(1):850-861. PubMed ID: 31680420
    [Abstract] [Full Text] [Related]

  • 7. Effect of HIF-1α/miR-10b-5p/PTEN on Hypoxia-Induced Cardiomyocyte Apoptosis.
    Wu L, Chen Y, Chen Y, Yang W, Han Y, Lu L, Yang K, Cao J.
    J Am Heart Assoc; 2019 Sep 17; 8(18):e011948. PubMed ID: 31480879
    [Abstract] [Full Text] [Related]

  • 8. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.
    Neckář J, Hsu A, Hye Khan MA, Gross GJ, Nithipatikom K, Cyprová M, Benák D, Hlaváčková M, Sotáková-Kašparová D, Falck JR, Sedmera D, Kolář F, Imig JD.
    Am J Physiol Heart Circ Physiol; 2018 Nov 01; 315(5):H1148-H1158. PubMed ID: 30074840
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
    Loinard C, Ginouvès A, Vilar J, Cochain C, Zouggari Y, Recalde A, Duriez M, Lévy BI, Pouysségur J, Berra E, Silvestre JS.
    Circulation; 2009 Jul 07; 120(1):50-9. PubMed ID: 19546390
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of hypoxia-inducible factor 1-alpha on hypoxia/reoxygenation-induced apoptosis in primary neonatal rat cardiomyocytes.
    Wang X, Ma S, Qi G.
    Biochem Biophys Res Commun; 2012 Jan 27; 417(4):1227-34. PubMed ID: 22227185
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
    Xia Y, Gong L, Liu H, Luo B, Li B, Li R, Li B, Lv M, Pan J, An F.
    Mol Cell Endocrinol; 2015 Mar 05; 403():21-9. PubMed ID: 25595486
    [Abstract] [Full Text] [Related]

  • 16. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
    Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA.
    Circ Res; 2006 Jan 06; 98(1):133-40. PubMed ID: 16306444
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium.
    Natarajan R, Salloum FN, Fisher BJ, Ownby ED, Kukreja RC, Fowler AA.
    Am J Physiol Heart Circ Physiol; 2007 Sep 06; 293(3):H1571-80. PubMed ID: 17545479
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.
    Liu S, Ai Q, Feng K, Li Y, Liu X.
    Apoptosis; 2016 Dec 06; 21(12):1366-1385. PubMed ID: 27738772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.